Trump administration to invest millions in psychedelics research for mental healthThe live-updates page leads with the Trump administration's plan to invest millions in psychedelics research: up to $4.9 million for ibogaine to treat veterans' PTSD and traumatic brain injuries, plus $20 million for other psychotropic drugs from the National Institute of Mental Health. It also covers a State Department report saying the U.S. managed more than $12 billion in Venezuelan oil revenue, Democrats expanding their probe of donors to Trump's ballroom, Donald Trump Jr. leaving his Kalshi advisory role over his firm's stake in rival Polymarket, Nvidia CEO Jensen Huang's resignation lifting AMD shares, and Washingtonian magazine staffers voting to strike.